Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Lung Adenocarcinoma
Related studies linked through entity extraction aliases.
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
- Status
- RECRUITING
- Phase
- NA
Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Radiomics-based Prediction Model of Tumor Spread Through Air Space in Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- N/A
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
IBI188 Combination Therapy in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cios Mobile 3D Spin for Robotic Bronchoscopy
- Status
- COMPLETED
- Phase
- N/A
A Study of PY314 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- NA
Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules
- Status
- UNKNOWN
- Phase
- N/A
TCM in the Treatment of Lung Adenocarcinoma
- Status
- UNKNOWN
- Phase
- NA
Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Lung Nodule Prospective Database
- Status
- COMPLETED
- Phase
- N/A
Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene
- Status
- UNKNOWN
- Phase
- PHASE2
Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2